Trial Profile
Phase IIa trial of a GM-CSF-adjuvanted HIV vaccine for the prevention of HIV infections.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2013
Price :
$35
*
At a glance
- Drugs GOVX-B11 (Primary)
- Indications HIV infections
- Focus Pharmacodynamics
- Sponsors GeoVax Labs
- 09 Nov 2013 New trial record